Carregant...
Institutional Experience of Using Andexanet Alfa
Given their ease of use, safety, and efficacy, direct-acting oral anticoagulants (DOACs) are nowadays widely used in patients with atrial fibrillation or venous thromboembolism, with or without an association with malignancy. Andexanet alfa (andexanet) is a recombinant modified human factor Xa decoy...
Guardat en:
| Publicat a: | Cureus |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Cureus
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425824/ https://ncbi.nlm.nih.gov/pubmed/32802609 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9173 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|